WorldCare Clinical

Richard Walovitch, Ph.D. has been named president of WorldCare Clinical, LLC (WCC). Dr. Walovitch previously served as chief medical officer, and will continue to provide medical leadership for the company. As president, he will have responsibility for directing operations, regulatory, sales and marketing activities, as well as play a vital role in defining the strategic vision of the company.

“This promotion is a reflection of Richard’s many contributions to WorldCare Clinical’s success in expanding the breadth and depth of our service offerings,” said managing director Michael O’Brien. “His years of experience and scientific contributions in the area of medical imaging assessment strategies and processes in clinical research have allowed our company to deliver high quality services to our clients in a timely and efficient manner.”

Dr. Walovitch joined the company in January 2009 as chief medical officer. He previously served as senior vice president of clinical research at Acusphere, where he was responsible for the development and implementation of clinical strategies for product candidates in multiple therapeutic areas.Prior to Acusphere, he served as vice president of preclinical and clinical research at Epix Medical, and held various positions as research pharmacologist and project clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Co.